Correlation Analysis on Risk Factors for Cervical Cancer in Perimenopausal Women

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2025 Feb 17

PMID 39959217

Authors

Ling Gong

Qingqing Xiao

Xiaofang Xie

Qiong Zheng

Affiliations

Soon will be listed here.

Abstract

Objective: To analyze the risk factors for cervical cancer in perimenopausal women.

Methods: The data of 380 cervical cancer patients and 380 healthy individuals undergoing physical examinations at the Health Management Center of West China Hospital, Sichuan University, between April 2022 and March 2023, were retrospectively analyzed. The baseline information, genetic characteristics, medical records (both past and present), menstrual cycles, healthy conditions of the reproductive system, and sexual activities of patients in the cervical cancer patient group and healthy control group were compared. Logistic regression analysis was conducted to evaluate the potential risk factors and to comprehensively assess the impact of these factors on the prevention of cervical cancer.

Results: Participants in the healthy control group showed a significantly lower age for first intercourse, first marriage and first pregnancy compared to those in the cervical cancer patient group. The proportions of married participants and those with a high school degree or above were higher in the healthy control group than those in the cervical cancer patient group. Additionally, the proportion of participants without a history of genetic diseases or any other diseases was significantly higher in the healthy control group than that in the cervical cancer patient group (P<0.05). The number of participants with regular menstrual cycles was significantly higher and the incidence of dysmenorrhea markedly lower in the healthy control group in comparison to the cervical cancer patient group (P<0.05). Meanwhile, the number of participants with only one pregnancy experience was higher and those with an abortion history was lower in the healthy control group than those in the cervical cancer patient group (P<0.05). Notably, more participants in the healthy control group preferred using contraception, underwent regular gynecological examinations and washed their external genitalia before sexual intercourse when compared to the cervical cancer patient group. Moreover, the healthy control group also had a higher proportion of participants who had sexual intercourses less than 4 times a week and who manually washed their underwear in comparison to the cervical cancer patient group (P<0.05). In addition, a total of 11 risk factors were identified to be in association with cervical cancer, which were human papillomavirus (HPV) testing (OR = 30.326), presence of reproductive system symptoms (OR = 27.605), dysmenorrhea (OR = 26.470), washing external genitalia before intercourse (OR = 0.430), passive smoking (OR = 16.119), duration of heating in winter (OR = 0.444), physical exercises (OR = 0.272), consumption of fried foods (OR = 8.240), vegetable intake (OR = 0.933), alcohol consumption (OR = 5.468), and consumption of chili peppers (OR = 4.797), listed in the order of their influential power.

Conclusion: Perimenopausal women should have a regular screening for cervical cancer during their hospital visits. More than that, they can seek to avoid risk factors in their daily life to prevent the occurrence of cervical cancer.

References

Cheng L, Gao Y, Xia Q, Wang H, Xie X, Liu Y . Reproductive tract microbiota of women in childbearing age shifts upon gynecological infections and menstrual cycle. BMC Microbiol. 2021; 21(1):252. PMC: 8454066. DOI: 10.1186/s12866-021-02300-4. View

Musa J, Achenbach C, ODwyer L, Evans C, McHugh M, Hou L . Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLoS One. 2017; 12(9):e0183924. PMC: 5584806. DOI: 10.1371/journal.pone.0183924. View

Mapanga W, Girdler-Brown B, Singh E . Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination. BMC Cancer. 2019; 19(1):845. PMC: 6712720. DOI: 10.1186/s12885-019-6060-z. View

Kamani M, Akgor U, Gultekin M . Review of the literature on combined oral contraceptives and cancer. Ecancermedicalscience. 2022; 16:1416. PMC: 9377820. DOI: 10.3332/ecancer.2022.1416. View

Finocchario-Kessler S, Wexler C, Maloba M, Mabachi N, Ndikum-Moffor F, Bukusi E . Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Womens Health. 2016; 16:29. PMC: 4893293. DOI: 10.1186/s12905-016-0306-6. View

Johnson C, James D, Marzan A, Armaos M . Cervical Cancer: An Overview of Pathophysiology and Management. Semin Oncol Nurs. 2019; 35(2):166-174. DOI: 10.1016/j.soncn.2019.02.003. View

Sun Y, Ma Y, Cao M, Hu Z, Lin W, Chen M . Breast and cervical cancer screening adherence in Jiangsu, China: An ecological perspective. Front Public Health. 2022; 10:967495. PMC: 9403787. DOI: 10.3389/fpubh.2022.967495. View

Alimena S, Pachigolla S, Feldman S, Yang D, Orio P, Lee L . Race- and Age-Related Disparities in Cervical Cancer Mortality. J Natl Compr Canc Netw. 2021; 19(7):789-795. DOI: 10.6004/jnccn.2020.7665. View

Yadav C, Yadav R, Chabbra R, Nanda S, Ranga S, Kadian L . Overview of genetic and epigenetic regulation of human papillomavirus and apoptosis in cervical cancer. Apoptosis. 2023; 28(5-6):683-701. DOI: 10.1007/s10495-023-01812-w. View

10.

Worsham C, Woo J, Zimerman A, Bray C, Jena A . Association of Maternal Cervical Disease With Human Papillomavirus Vaccination Among Offspring. JAMA Netw Open. 2021; 4(12):e2134566. PMC: 8669541. DOI: 10.1001/jamanetworkopen.2021.34566. View

11.

Voelker R . Cervical Cancer Screening. JAMA. 2023; 330(20):2030. DOI: 10.1001/jama.2023.21987. View

12.

Zhu X, Yao Q, Dai W, Ji L, Yao Y, Pang B . Cervical cancer screening aided by artificial intelligence, China. Bull World Health Organ. 2023; 101(6):381-390. PMC: 10225939. DOI: 10.2471/BLT.22.289061. View

13.

Esmaeili Gouvarchin Ghaleh H, Shahriary A, Izadi M, Farzanehpour M . Advances in early diagnosis of cervical cancer based on biosensors. Biotechnol Bioeng. 2022; 119(9):2305-2312. DOI: 10.1002/bit.28149. View

14.

Wu B, Xi S . Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. BMC Cancer. 2021; 21(1):733. PMC: 8236200. DOI: 10.1186/s12885-021-08412-4. View

15.

Kumar N, Kalyani K, Sharma A, Sivakoti S, Mangla M . Uncommon Location for a Common Disease, Simulating Cervical Cancer: A Rare Case Report. Infect Disord Drug Targets. 2023; 24(1):e220823220210. DOI: 10.2174/1871526523666230822155148. View

16.

Guo M, Xu J, Du J . Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis. BMC Public Health. 2021; 21(1):1329. PMC: 8259057. DOI: 10.1186/s12889-021-11401-8. View

17.

Mohammed F, Tune K, Jett M, Muhie S . Cervical Cancer Stages, Human Papillomavirus Integration, and Malignant Genetic Mutations: Integrative Analysis of Datasets from Four Different Cohorts. Cancers (Basel). 2023; 15(23). PMC: 10705285. DOI: 10.3390/cancers15235595. View

18.

Gavinski K, DiNardo D . Cervical Cancer Screening. Med Clin North Am. 2023; 107(2):259-269. DOI: 10.1016/j.mcna.2022.10.006. View

19.

Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X . Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infect. 2023; 12(1):e2176009. PMC: 9936994. DOI: 10.1080/22221751.2023.2176009. View

20.

Donley T, Ilunga Tshiswaka D, Blanc J, Seixas A, Okafor A, Mbizo J . Differences in Breast and Cervical Cancer Screening Among U.S. Women by Nativity and Family History. Am J Prev Med. 2020; 59(4):578-587. DOI: 10.1016/j.amepre.2020.05.018. View